Halozyme Therapeutics Inc (NASDAQ:HALO)

15.89
Delayed Data
As of Apr 20
 +0.59 / +3.86%
Today’s Change
6.88
Today|||52-Week Range
16.55
+64.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash----21.6M61.4M
 
 
 
Short Term Investment Cash-30.4M47.1M-72.0M34.0M
 
 
 
 
 
Cash & Short Term Investments52.8M99.9M71.5M135.6M
 
 
 
 
 
 
ReceivablesReceivables2.3M15.7M9.1M9.1M
 
 
 
 
 
 
InventoriesInventories567.3K2.7M6.2M6.4M
 
 
 
 
 
 
Current AssetsOther Current Assets8.3M12.8M8.4M10.1M
 
 
 
 
 
Current Assets64.0M131.0M95.2M161.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross7.5M10.4M11.1M12.2M
 
 
 
 
 
Depreciation-5.7M-6.7M-7.6M-9.2M
 
 
 
 
 
Other Assets0.000.002.7M1.2M
 
 
 
Total Assets65.8M134.7M101.8M166.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable7.6M2.3M3.1M3.0M
 
 
 
 
 
Accrued Expenses2.4M3.7M7.8M8.0M
 
 
 
 
 
Other Current Liabilities6.5M12.6M15.2M15.4M
 
 
 
 
 
Other Liabilities17.3M18.9M25.5M24.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.0031.1M49.8M49.9M
 
 
 
 
Other Liabilities0.000.0018.3K3.2M
 
 
 
Total Liabilities54.9M85.9M121.8M124.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity10.9M48.9M-20.0M41.4M
 
 
 
 
 
Total Shareholder Equity10.9M48.9M-20.0M41.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding104.0M112.7M114.5M125.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account